News Headlines Article

FDA Approves First Drug To Boost Women’s Sexual Desire
National Public Radio

The Food and Drug Administration approved the first drug designed to increase a woman’s libido.

The controversial decision was hailed by some doctors and advocates as a long-sought victory for women’s health, but was condemned by others as irresponsible and dangerous.

The little pink pill, known generically as flibanserin, will be sold under the brand name Addyi beginning Oct. 17, according to its maker, Sprout Pharmaceuticals. The medicine is to be taken daily to treat premenopausal women suffering from hypoactive sexual desire disorder, which is essentially a sudden, unexplained loss of any desire to have sex.

Commands